Laboratory/pathology

From clinical chemistry to digital pathology: Read more about how modern medical laboratories and procedures in pathology play a vital role in the detection and prevention of diseases and in medical research.

Photo

Video • Early detection of dementias

Promising sensor to screen for Alzheimer's

Canadian researchers are developing a new, ultra-sensitive biosensor to screen for Alzheimer’s disease and other diseases. The device has successfully completed the proof-of-concept stage.

Photo

News • Technology transition

Netherlands Cancer Institute switches to new digital pathology platform

The Netherlands Cancer Institute (NKI) will deploy a diagnostic platform from digital and computational pathology solutions provider Proscia, the company announced.

Photo

News • Neurodegeneration assessment

New blood test differentiates Alzheimer’s disease from other dementias

A new blood test that can track and follow the neurodegeneration in Alzheimer's disease - and exclude other dementias.

Photo

Article • Centralised image library and archive

From regional to national: digital pathology network transformation

Transforming a regional digital pathology network into a national programme across the UK has the potential to save the NHS around £100m a year. Such a network – one that sees a centralised digital pathology image library and archive, as opposed to individual hospitals having their own infrastructure and teams to manage it – can also offer a range of other benefits alongside significant cost savings.

Photo

News • Specialized immune cells

γδ T cells carry potential for new cancer immunotherapies

Dutch scientists have discovered how specialized immune cells can detect and remove cancers that are ‘invisible’ to the conventional defense mechanisms of the immune system.

Photo

News • Unexpected reactivation

BYOB (Bring your own bacteria) as cause of hospital infections?

Some hospitalized patients’ infections may develop from their own bacteria, new research results suggest. The study in mice indicates that medical interventions can awaken dormant, hidden bacteria.

Photo

News • Intestinal distress

Multiple sclerosis: a closer look at the gut microbiome

​Findings of bacteria with anti-inflammatory effects in the intestines of MS patients with no evidence of active disease indicate that diet, bacteria and disease progression are linked.

Products from Labbook

KABE Labortechnik – Consumables Test Tubes

Blood Collection

KABE Labortechnik – Consumables Test Tubes

KABE LABORTECHNIK GmbH
Sarstedt – Tempus600 Quantit

Sample Logistics

Sarstedt – Tempus600 Quantit

SARSTEDT AG & CO. KG
Sysmex – XN-9100

Integrated Hematology

Sysmex – XN-9100

Sysmex Europe GmbH
KABE Labortechnik – Consumables for blood gas analysis

Blood Gases /Electrolytes /Oximetry

KABE Labortechnik – Consumables for blood gas analysis

KABE LABORTECHNIK GmbH
Photo

Sponsored • Disease management

Multiplex Testing: A Solution to Manage Surge in Respiratory Illnesses as Concerns over “Multi-demic” Rise

Eunsin Bae, M.D. specializes in laboratory medicine and leads the Institute of Clinical Research at Seegene Inc. Her research focuses on microbiology, molecular biology, and hematology. Dr. Bae is currently working toward implementing a global clinical study and establishing an international network of clinical investigations.

Photo

Article • Tissue-engineered glioblastoma model

3D brain tumour in a dish to personalize cancer treatment

It is the size of a common pencil eraser, but it could have a huge impact on the therapy of glioblastoma: Scientists in Virginia have developed a novel 3D tissue-engineered model of the brain tumour microenvironment, which can be used to assess how the glioma cell invades healthy tissue, proliferates, and reacts to chemotherapy drugs.

Photo

Article • Early detection approach

Multi-cancer blood tests could shake up screening

New tests can identify over 50 types of cancer and boost detection of traditionally elusive cancers from tumour DNA in blood, researchers showed at the ESMO congress in September. These multi-cancer early detection (MCED) tests in development can spot common cancer signals and predict where the signal comes from in the body, results from a prospective investigation suggest.

Photo

Lab-on-a-chip

Multiplexed lab-on-a-chip bioassays for testing antibodies against SARS-CoV 2 and its variants in multiple individuals

The coronavirus pandemic caused by SARS-CoV-2 and its variants is still a major public safety issue worldwide. The “alpha” variant B.1.1.7, the “gamma” variant P.1, the “beta” variant B.1.351, and the “delta” variant B.1.617 are of particular concern because of their high prevalence. Large-scale vaccination and sensitive detection are vital for preventing the spread of Covid-19.

1526 show more articles
Subscribe to Newsletter